Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 49.60
-0.60 (-1.20%)
Jun 2, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 622.27 million as of June 2, 2026. Its market cap has increased by 14.50% in one year.
Market Cap
622.27M
Enterprise Value
551.69M
Revenue
232.38M
Ranking
n/a
PE Ratio
15.98
Stock Price
49.60
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has increased from 533.29M to 622.27M, an increase of 16.68%. That is a compound annual growth rate of 0.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 622.27M | -7.42% |
| Dec 30, 2025 | 672.13M | 34.10% |
| Dec 30, 2024 | 501.21M | 18.52% |
| Dec 29, 2023 | 422.90M | -22.52% |
| Dec 30, 2022 | 545.84M | 12.62% |
| Dec 30, 2021 | 484.67M | -15.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.76B |
| Idorsia | 1.14B |
| Newron Pharmaceuticals | 272.60M |
| Santhera Pharmaceuticals Holding AG | 227.35M |
| BioVersys AG | 157.90M |
| Xlife Sciences AG | 132.65M |
| Molecular Partners AG | 117.47M |
| MindMaze Therapeutics Holding | 57.00M |